Physician profile
Stephen E Pierotti
NPI 1154328029
$1,227.56
in general payments reported to CMS, 2019-2025
12 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.49 · 2020: $271 · 2021: $175 · 2022: $143 · 2023: $132 · 2024: $71.98 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $691.31 | 2019-2025 | Velys, Na, Attune |
| Stryker Corporation | $231.31 | 2021-2025 | Alphavent, Inspace, T2 |
| Wardlow Enterprises | $90.96 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $53.64 | 2025 | |
| Smith+Nephew, INC. | $31.86 | 2020 | |
| Ferring Pharmaceuticals INC. | $27.37 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.49 | 2024 | Zilretta, Iovera, Exparel |
| Bioventus LLC | $21.09 | 2019 | |
| Endo Pharmaceuticals INC. | $14.78 | 2022 | |
| Medical Device Business Services, INC. | $14.50 | 2021 | |
| Nuvasive, INC. | $14.17 | 2019 | |
| Sanara Medtech INC. | $14.08 | 2023 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Pierotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.